Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2015/027401, filed Apr 23, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,208,137 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | ||
| US 12,296,010 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | ||
| US 11,400,115 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | ||
| Application 17/850,875 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Abandoned Abandoned Aug 8, 2026 | Juno Therapeutics, Inc. | Abandoned | Abandoned Aug 8, 2026 | not computed | |
| Application 19/570,009 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 19/570,013 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 19/570,016 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 19/029,968 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 19/030,019 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 19/030,056 | Methods for Isolating, Culturing, and Genetically Engineering Immune Cell Populations for Adoptive Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed | |
| 1 more patent in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
3 of these are in force and held by Juno, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.